Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer

BackgroundRecent genome-wide analysis has shown that DNA methylation spans long stretches of chromosome regions consisting of clusters of contiguous CpG islands or gene families. Hypermethylation of various gene clusters has been reported in many types of cancer. In this study, we conducted methyl-binding domain capture (MBDCap) sequencing (MBD-seq) analysis on a breast cancer cohort consisting of 77 patients and 10 normal controls, as well as a panel of 38 breast cancer cell lines.ResultsBioinformatics analysis determined seven gene clusters with a significant difference in overall survival (OS) and further revealed a distinct feature that the conservation of a large gene cluster (approximately 70 kb) metallothionein-1 (MT1) among 45 species is much lower than the average of all RefSeq genes. Furthermore, we found that DNA methylation is an important epigenetic regulator contributing to gene repression of MT1 gene cluster in both ERα positive (ERα+) and ERα negative (ERα−) breast tumors. In silico analysis revealed much lower gene expression of this cluster in The Cancer Genome Atlas (TCGA) cohort for ERα + tumors. To further investigate the role of estrogen, we conducted 17β-estradiol (E2) and demethylating agent 5-aza-2′-deoxycytidine (DAC) treatment in various breast cancer cell types. Cell proliferation and invasion assays suggested MT1F and MT1M may play an anti-oncogenic role in breast cancer.ConclusionsOur data suggests that DNA methylation in large contiguous gene clusters can be potential prognostic markers of breast cancer. Further investigation of these clusters revealed that estrogen mediates epigenetic repression of MT1 cluster in ERα + breast cancer cell lines. In all, our studies identify thousands of breast tumor hypermethylated regions for the first time, in particular, discovering seven large contiguous hypermethylated gene clusters.

[1]  C. Ricketts,et al.  Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.

[2]  T. Sugimura,et al.  Identification of 20 genes aberrantly methylated in human breast cancers , 2005, International journal of cancer.

[3]  I. Thompson,et al.  Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer , 2013, Clinical Cancer Research.

[4]  Neal P. Kawas,et al.  Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. , 2014, Human molecular genetics.

[5]  In Ah Kim,et al.  Promoter CpG island hypermethylation during breast cancer progression , 2010, Virchows Archiv.

[6]  T. Rauch,et al.  CpG island hypermethylation in human astrocytomas. , 2010, Cancer research.

[7]  Kenneth P. Nephew,et al.  Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers , 2013, Epigenetics.

[8]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[9]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[10]  Huang,et al.  Metallothionein MT 1 M is a tumor suppressor of human hepatocellular carcinomas , 2012 .

[11]  B. Dutrillaux,et al.  Distinct patterns of all‐trans retinoic acid dependent expression of HOXB and HOXC homeogenes in human embryonal and small‐cell lung carcinoma cell lines , 1997, FEBS Letters.

[12]  Mark S. Doderer,et al.  CMS: A Web-Based System for Visualization and Analysis of Genome-Wide Methylation Data of Human Cancers , 2013, PloS one.

[13]  Jia Liu,et al.  PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer. , 2012, Histology and histopathology.

[14]  G. Puca,et al.  The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. , 2004, Cancer letters.

[15]  Clare Stirzaker,et al.  Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band , 2006, Nature Genetics.

[16]  B. Teh,et al.  Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer , 2012, Science Translational Medicine.

[17]  E. Appella,et al.  Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. , 2006, Cancer cell.

[18]  Jose Russo,et al.  Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. , 2010, Genome research.

[19]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[20]  Christofer L. Bäcklin,et al.  Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia , 2013, Genome Biology.

[21]  A. Riggs,et al.  Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay , 2007, Proceedings of the National Academy of Sciences.

[22]  A. Amorim,et al.  Gains, Losses and Changes of Function after Gene Duplication: Study of the Metallothionein Family , 2011, PloS one.

[23]  Taylor Jensen,et al.  Epigenetic inactivation of the HOXA gene cluster in breast cancer. , 2006, Cancer research.

[24]  Kathy Pritchard-Jones,et al.  Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor , 2009, PLoS genetics.

[25]  P. Tan,et al.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. , 2003, The American journal of pathology.

[26]  Susan J Clark,et al.  Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. , 2007, Human molecular genetics.

[27]  Xiao Han,et al.  ERα positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells. , 2012, Biochemical and biophysical research communications.

[28]  Jingde Zhu,et al.  Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. , 2012, Carcinogenesis.

[29]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[30]  M. Esteller,et al.  A prognostic DNA methylation signature for stage I non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Michael Q. Zhang,et al.  Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells , 2013, Cell.

[32]  T. Nakajima,et al.  Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. , 1996, Oncology.

[33]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.

[34]  Zhongli Yang,et al.  Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells , 2009, Molecular Biology Reports.

[35]  E. Birney,et al.  An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). , 2008, Genome research.

[36]  S. Garrett,et al.  Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines. , 1998, The American journal of pathology.

[37]  Xun Lan,et al.  Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer. , 2013, Cancer cell.

[38]  Michael J. Terry,et al.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.

[39]  Wim Van Criekinge,et al.  Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. , 2008, Cancer research.

[40]  F. Antequera,et al.  Structure, function and evolution of CpG island promoters , 2003, Cellular and Molecular Life Sciences CMLS.

[41]  Gavin D. Meredith,et al.  High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology , 2011, PloS one.

[42]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[43]  Sandya Liyanarachchi,et al.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. , 2006, Molecular cell.

[44]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.